September 16-17, 2025
Sheraton BostonBoston, MAFinance & Accounting Attendees
CFOs, Chief Accountants, and VPs of Finance & Accounting
| Vice President, Finance — Corbus Pharmaceuticals |
| Chief Financial Officer — Eisai |
| Vice President & Chief Accounting Officer — Intellia Therapeutics |
| Chief Financial Officer — Collegium Pharmaceuticals |
| Chief Financial Officer — InVivo Biosystems |
| Vice President & Corporate Controller — Longeveron |
| Chief Financial Officer & Head of Operations — Radius Health |
| Vice President of Finance & Treasurer — Sail Biomedicines |
| Vice President of Finance — Structure Therapeutics |
| Vice President & Controller — Orbital Therapeutics |
| Vice President, Financial Planning & Analysis — Intellia Therapeutics |
| Vice President, Controller — Agios Pharmaceuticals |
| Chief Financial Officer — Alentis Therapeutics |
| Vice President of Finance — Alkeus Pharmaceuticals |
| Chief Financial Officer — Ascidian Therapeutics |
| Vice President, Finance — Biotheryx |
| Vice President, Financial Planning & Analysis — Collegium Pharmaceuticals |
| Vice President, Strategic Finance — EyePoint Pharmaceuticals |
| Chief Accounting Officer — Immuneering |
| Vice President, Chief Accounting Officer — Mersana Therapeutics |
| Board Member — Neuropace |
| Vice President, Finance & Controller — PepGen |
| Chief Financial Officer — X4 Pharmaceuticals |
| Chief Accounting Officer — Centessa Pharmaceuticals |
Controllers, Directors, & Heads of Finance & Accounting
With Over 60% Attending with Their Team
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Regulatory Bodies
|
|